AS
Annabel Samimy Stifel Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Ligand Pharmaceuticals
LGND
$3.23B
| $165.41 | $143 |
14%
downside
| Buy |
10 Apr ‘25
5 months ago |
|
|
PVLA
2
Palvella Therapeutics, Inc. Common Stock
PVLA
$609M
| $56.71 | $45 |
21%
downside
| Buy |
26 Mar ‘25
5 months ago |
|
3
Structure Therapeutics
GPCR
$1.2B
| $21.25 | $50 |
135%
upside
| Buy |
8 Jan ‘25
8 months ago |
|
4
Altimmune
ALT
$327M
| $3.78 | $18 |
376%
upside
| Buy |
8 Jan ‘25
8 months ago |
|
|
IVA
5
Inventiva
IVA
$747M
| $5.36 | $17 |
217%
upside
| Buy |
22 Nov ‘24
9 months ago |
|
|
MBX
6
MBX Biosciences, Inc. Common Stock
MBX
$366M
| $11.42 | $40 |
250%
upside
| Buy |
8 Oct ‘24
11 months ago |
|
7
Kamada
KMDA
$415M
| $7.15 | $18 |
152%
upside
| Buy |
3 Jul ‘24
1 year ago |
|
8
Phathom Pharmaceuticals
PHAT
$882M
| $12.89 | $24 |
86%
upside
| Buy |
3 May ‘24
1 year ago |
|
9
Regenxbio
RGNX
$479M
| $9.89 | $40 |
304%
upside
| Buy |
12 Apr ‘24
1 year ago |
|
10
Viking Therapeutics
VKTX
$2.87B
| $25.27 | $80 |
217%
upside
| Buy |
15 Mar ‘24
1 year ago |
|
11
Jazz Pharmaceuticals
JAZZ
$7.88B
| $128.53 | $230 |
79%
upside
| Buy |
15 Mar ‘24
1 year ago |
|
12
Evolus
EOLS
$492M
| $7.39 | $25 |
238%
upside
| Buy |
8 Mar ‘24
1 year ago |
|
13
Oculis Holding
OCS
$903M
| $17.19 | $35 |
104%
upside
| Buy |
5 Oct ‘23
1 year ago |
|
14
Apellis Pharmaceuticals
APLS
$3.4B
| $26.84 | $65 |
142%
upside
| Buy |
29 Aug ‘23
2 years ago |
|
|
TVRD
15
Tvardi Therapeutics, Inc. Common Stock
TVRD
$278M
| $31.82 | $1,008 |
3,068%
upside
| Buy |
27 Jun ‘23
2 years ago |
|
16
FibroGen
FGEN
$45.1M
| $11.48 | $275 |
2,295%
upside
| Hold |
26 Jun ‘23
2 years ago |
|
17
Mineralys Therapeutics
MLYS
$2.79B
| $38.50 | $45 |
17%
upside
| Buy |
7 Mar ‘23
2 years ago |
|
18
Clearside Biomedical
CLSD
$26.4M
| $0.3387 | $8 |
2,262%
upside
| Buy |
10 Nov ‘22
2 years ago |
|
19
Elicio Therapeutics
ELTX
$191M
| $11.62 | $15 |
29%
upside
| Hold |
30 Jun ‘22
3 years ago |
|
20
Rani Therapeutics
RANI
$23.9M
| $0.4994 | $24 |
4,706%
upside
| Buy |
24 Aug ‘21
4 years ago |
|
21
TherapeuticsMD
TXMD
$12.5M
| $1.08 | $750 |
69,344%
upside
| Buy |
16 Apr ‘20
5 years ago |
|
22
Supernus Pharmaceuticals
SUPN
$2.57B
| $46.03 | $24 |
48%
downside
| Hold |
16 Apr ‘20
5 years ago |
|